Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04287114
Other study ID # T24/2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 8, 2021
Est. completion date December 31, 2021

Study information

Verified date February 2021
Source Turku University Hospital
Contact Ilkka HA Heinonen, PhD
Phone 408393962
Email ilkka.heinonen@utu.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main aim of the present investigation is to study cardiac function in different exercise intensities in healthy human subjects. Two techniques will be used: cardiac ultrasound-derived stroke volume measurements and body impedance measurements. 20 healthy men (n=10) and women (n=10) aged 18-45 years will be investigated at rest and during exercise. All study procedures are non-invasive.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Age 18-45 - BMI 18-30 - Resting Blood pressure < 140/90 mmHg - Participation in regular exercise Exclusion Criteria: - Acute illness - Pregnancy - Pace maker - Artificial joint - History of a cardiac event - Insulin or medically treated diabetes - Any chronic disease or condition that could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results - Abundant use of alcohol - Use of narcotics - Smoking of tobacco or consuming snuff tobacco - Diagnosed depressive or bipolar disorder - Abnormalities in resting ECG (revised by the study physician)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Acute exercise
Acute exercise with different exercise intensities

Locations

Country Name City State
Finland Turku PET Centre Turku
Finland University of Turku Turku

Sponsors (1)

Lead Sponsor Collaborator
Turku University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac stroke volume 1 min
Secondary End-diastolic and end-systolic volumes 1 min
Secondary Ejection fraction 1 min
See also
  Status Clinical Trial Phase
Completed NCT04577430 - Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period N/A
Recruiting NCT01881945 - Validation of Study in Respiratory Physiology and it Interactions N/A
Terminated NCT04538079 - Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
Recruiting NCT05662995 - Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia N/A
Recruiting NCT04455477 - Nesiritide for Ventilated Congestive Heart Failure
Recruiting NCT05698277 - Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
Completed NCT01352403 - Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention N/A
Completed NCT00970463 - Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly N/A
Completed NCT01443780 - Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden N/A
Completed NCT04529187 - Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study. Phase 4
Withdrawn NCT00882622 - Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery Phase 1
Recruiting NCT03805776 - Intermittent Fasting in Dyslipidemia N/A
Recruiting NCT05962190 - Short-term Fat Overfeeding on the Effects of Liver Metabolism N/A
Completed NCT04629937 - Evaluation of Whole-body CZT Camera in Gated Tomographic Radionuclide Angiography N/A
Completed NCT01026012 - Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing N/A
Completed NCT03445221 - Preoperative Immunonutrition and Cardiac Patients Phase 2/Phase 3